The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).
According to a government official, the use of Azithromycin was not "much beneficial" on coronavirus patients.
However, the antiviral drug HCQ will be used both on moderate and severe COVID-19 patients.
The Union Health Ministry is likely to amend the existing COVID-19 clinical management guidelines issued by the central government.
( With inputs from ANI )